31P MRSI and 1H MRS at 7T: Initial results in human breast cancer

NMR in Biomedicine

Volumn 24, Issue 10, 2011, Pages 1337-1342

  Klomp, Dennis W J ^a   van de Bank, Bart L ^a   Raaijmakers, Alexander ^a   Korteweg, Mies A ^a   Possanzini, Cecilia ^b   Boer, Vincent O ^a   van de Berg, Cornelius A T ^a   van de Bosch, Maurice A A J ^a   Luijten, Peter R ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b PHILIPS HEALTHCARE   (United States)

Author keywords

7T; 31P MRS; Breast cancer; Choline; Energy metabolism; Phospholipid metabolism

Indexed keywords

7T; 31P MRS; BREAST CANCER; CHOLINE; ENERGY METABOLISM;

CHEMOTHERAPY; DISEASES; GLYCEROL; METABOLISM; NONINVASIVE MEDICAL PROCEDURES; PHOSPHOLIPIDS; PHYSIOLOGY; TUMORS;

MEDICAL IMAGING;

ADENOSINE; CHOLINE DERIVATIVE; CYCLOPHOSPHAMIDE; DIACYLGLYCEROL KINASE; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; NUCLEOSIDE TRIPHOSPHATE; PHOSPHATE; PHOSPHOETHANOLAMINE; PHOSPHOLIPID; PHOSPHORUS 31; PHOSPHORYLCHOLINE; PHOSPHORUS;

ADULT; ADVANCED CANCER; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CASE REPORT; CELL PH; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENERGY METABOLISM; EX VIVO STUDY; FEASIBILITY STUDY; FEMALE; HUMAN; IN VIVO STUDY; LIMIT OF QUANTITATION; METABOLISM; MORPHOLOGY; MULTIPLE CYCLE TREATMENT; NON INVASIVE PROCEDURE; NUCLEAR MAGNETIC RESONANCE IMAGING; PHOSPHOLIPID METABOLISM; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTON NUCLEAR MAGNETIC RESONANCE; RADIOFREQUENCY; SENSITIVITY ANALYSIS; THREE DIMENSIONAL IMAGING; BREAST TUMOR; COMPUTER SIMULATION; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;

ADULT; BREAST NEOPLASMS; COMPUTER SIMULATION; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; PHOSPHORUS ISOTOPES;

EID: 84855319111     PISSN: 09523480     EISSN: 10991492     Source Type: Journal    
DOI: 10.1002/nbm.1696     Document Type: Article

References (23)

1. Katz-Brull R, Seger D, Rivenson-Segal D, Rushkin E, Degani H. Metabolic markers of breast cancer: enhanced choline metabolism and reduced choline-ether-phospholipid synthesis. Cancer Res. 2002; 62(7): 1966-1970.
2. Al-Saffar NM, Troy H, Ramírez de Molina A, Jackson LE, Madhu B, Griffiths JR, Leach MO, Workman P, Lacal JC, Judson IR, Chung YL. Noninvasive magnetic resonance spectroscopic pharmacodynamic markers of the choline kinase inhibitor MN58b in human carcinoma models. Cancer Res. 2006; 66(1): 427-434.
3. 31P-magnetic resonance spectroscopy study. Cancer Res. 2001; 61(20): 7536-7543.
4. Schelling M, Avril N, Nährig J, Kuhn W, Römer W, Sattler D, Werner M, Dose J, Jänicke F, Graeff H, Schwaiger M. Positron emission tomography using [(18)F]Fluorodeoxyglucose for monitoring primary chemotherapy in breast cancer. J. Clin. Oncol. 2000; 18(8): 1689-1695.
5. Haddadin IS, McIntosh A, Meisamy S, Corum C, Styczynski Snyder AL, Powell NJ, Nelson MT, Yee D, Garwood M, Bolan PJ. Metabolite quantification and high-field MRS in breast cancer. NMR Biomed. 2009; 22(1): 65-76.
6. 31P MRS study. Br. J. Cancer, 1993; 67: 1145-1153.
7. Dunnwald LK, Gralow JR, Ellis GK, Livingston RB, Linden HM, Specht JM, Doot RK, Lawton TJ, Barlow WE, Kurland BF, Schubert EK, Mankoff DA. Tumor metabolism and blood flow changes by positron emission tomography: relation to survival in patients treated with neoadjuvant chemotherapy for locally advanced breast cancer. J. Clin. Oncol. 2008; 26(27): 4449-4457.
8. Robey IF, Baggett BK, Kirkpatrick ND, Roe DJ, Dosescu J, Sloane BF, Hashim AI, Morse DL, Raghunand N, Gatenby RA, Gillies RJ. Bicarbonate increases tumor pH and inhibits spontaneous metastases. Cancer Res. 2009; 69(6): 2260-2268.
9. Mellon EA, Lee SC, Pickup S, Kim S, Goldstein SC, Floyd TF, Poptani H, Delikatny EJ, Reddy R, Glickson JD. Detection of lactate with a hadamard slice selected, selective multiple quantum coherence, chemical shift imaging sequence (HDMD-SelMQC-CSI) on a clinical MRI scanner: application to tumors and muscle ischemia. Magn. Reson. Med. 2009; 62(6): 1404-1413.
10. Haselgrove JC, Subramanian VH, Leigh JS, Gyulai L, Chance B. In vivo one-dimensional imaging of phosphorus metabolites by P-31 nuclear magnetic resonance. Science, 1983; 220: 1170-1173.
11. Podo F. Tumour phospholipid metabolism. NMR Biomed. 1999; 12(7): 413-439.
12. 31P magnetic resonance spectroscopy for monitoring treatment response in breast cancer. Lancet, 1989; 1(8650): 1326-1327.
13. 31P measurements of response to treatment. NMR Biomed. 1998; 11(7): 314-340.
14. Arias-Mendoza F, Zakian K, Schwartz A, Howe FA, Koutcher JA, Leach MO, Griffiths JR, Heerschap A, Glickson JD, Nelson SJ, Evelhoch JL, Charles HC, Brown TR. Methodological standardization for a multi-institutional in vivo trial of localized P-31 MR spectroscopy in human cancer research. In vitro and normal volunteer studies. NMR Biomed. 2004; 17: 382-391.
15. Versluis MJ, Kan HE, van Buchem MA, Webb AG. Improved signal to noise in proton spectroscopy of the human calf muscle at 7T using localized B1 calibration. Magn. Reson. Med. 2010; 63(1): 207-211.
16. Shen J, Rycyna RE, Rothman DL. Improvements on an in vivo automatic shimming method [FASTERMAP]. Magn. Reson. Med. 1997; 38(5): 834-839.
17. 1H-MRSI of the human brain at 3T with minimal chemical shift displacement errors using adiabatic refocusing pulses. Magn. Reson. Med. 2008; 59(1): 1-6.
18. Mescher M, Tannus A, Johnson MO, Garwood M. Solvent suppression using selective echo dephasing. J. Magn. Reson. A, 1996; 123: 226-229.
19. Pohmann R, von Kienlin M. Accurate phosphorus metabolite images of the human heart by 3D acquisition-weighted CSI. Magn. Reson. Med. 2001; 45(5): 817-826.
20. 31P polarization transfer on a clinical 3T MR system. Magn. Reson. Med. 2008; 60(6): 1298-1305.
21. Negendank W. Studies of human tumors by MRS: a review. NMR Biomed. 1992; 5(5): 303-324.
22. 31P NMR spectra from human breast tumours: variations in phospholipid metabolism. Br. J. Cancer, 1991; 63(4): 514-516.
23. 31P NMR spectroscopy. NMR Biomed. 1991; 4: 262-267.